Novartis (NVS) News Today $103.09 -0.18 (-0.17%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Novartis Lifts Sales Outlook on Key Drugs, Pipeline PortfolioNovember 21 at 5:06 AM | wsj.comPathstone Holdings LLC Lowers Position in Novartis AG (NYSE:NVS)Pathstone Holdings LLC lowered its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 23.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 103,150 shares of the company's stock after selling 32,1November 21 at 4:20 AM | marketbeat.comMAI Capital Management Sells 19,168 Shares of Novartis AG (NYSE:NVS)MAI Capital Management lessened its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 52.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,589 shares of the company's stock after selling 19,168 shares during the period. MAI CaNovember 21 at 4:10 AM | marketbeat.comNovartis: launch of Morphosys drug by could be 2027 or laterNovember 21 at 3:12 AM | reuters.comNovartis raises annual sales guidance until 2028November 21 at 1:15 AM | reuters.comNovartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growthNovember 21 at 1:00 AM | globenewswire.comNovartis downgraded to Hold from Buy at Erste GroupNovember 20 at 7:29 AM | markets.businessinsider.comCIBC Asset Management Inc Sells 5,194 Shares of Novartis AG (NYSE:NVS)CIBC Asset Management Inc cut its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 21.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,089 shares of the company's stock afterNovember 20 at 3:58 AM | marketbeat.comNovartis (NYSE:NVS) Earns "Hold" Rating from Erste Group BankErste Group Bank restated a "hold" rating on shares of Novartis in a report on Tuesday.November 19 at 12:53 PM | marketbeat.comNovartis ranks first in 2024 Access to Medicine IndexNovember 19 at 8:00 AM | globenewswire.comNovartis AG (NYSE:NVS) Shares Sold by AMG National Trust BankAMG National Trust Bank trimmed its position in shares of Novartis AG (NYSE:NVS - Free Report) by 22.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,991 shares of the company's stock after selling 6,496 shares during the quarter. AMGNovember 19 at 5:12 AM | marketbeat.comRatio Therapeutics, Novartis Pharma Partner To Develop Radiotherapeutic Candidate For CancerNovember 18 at 5:49 PM | markets.businessinsider.comNovartis, Radio Therapeutics enter license, collaboration agreementNovember 18 at 5:49 PM | markets.businessinsider.comNovartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancerNovember 18 at 5:49 PM | msn.comRatio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic CandidateNovember 18 at 8:00 AM | prnewswire.comNovartis says Pluvicto talks in Canada end without agreementNovember 16, 2024 | markets.businessinsider.comNovartis says Pluvicto talks in Canada end without agreementNovember 16, 2024 | markets.businessinsider.comNatixis Advisors LLC Purchases 26,317 Shares of Novartis AG (NYSE:NVS)Natixis Advisors LLC raised its holdings in Novartis AG (NYSE:NVS - Free Report) by 2.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 938,844 shares of the company's stock after buying an additional 26,317 shares duringNovember 16, 2024 | marketbeat.comCoastline Trust Co Increases Holdings in Novartis AG (NYSE:NVS)Coastline Trust Co grew its holdings in Novartis AG (NYSE:NVS - Free Report) by 41.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 20,621 shares of the company's stock after acquiring an additional 6,060 shares during the quarter. CoastliNovember 16, 2024 | marketbeat.comBroderick Brian C Decreases Holdings in Novartis AG (NYSE:NVS)Broderick Brian C trimmed its holdings in Novartis AG (NYSE:NVS - Free Report) by 36.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,033 shares of the company's stock after selling 6,780 shares duringNovember 15, 2024 | marketbeat.comZacks Research Analysts Cut Earnings Estimates for NovartisNovartis AG (NYSE:NVS - Free Report) - Equities research analysts at Zacks Research cut their Q4 2024 earnings estimates for shares of Novartis in a note issued to investors on Tuesday, November 12th. Zacks Research analyst E. Bagri now expects that the company will post earnings of $1.76 per shaNovember 15, 2024 | marketbeat.comNovartis FY2024 EPS Estimate Increased by Zacks ResearchNovartis AG (NYSE:NVS - Free Report) - Zacks Research upped their FY2024 EPS estimates for Novartis in a research report issued on Tuesday, November 12th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings of $7.59 per share for the year, up from their prior estimNovember 14, 2024 | marketbeat.comOppenheimer Asset Management Inc. Sells 60,212 Shares of Novartis AG (NYSE:NVS)Oppenheimer Asset Management Inc. decreased its position in Novartis AG (NYSE:NVS - Free Report) by 20.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 229,901 shares of the company's stock after selling 60,212 shares during the quarteNovember 13, 2024 | marketbeat.comSaturna Capital Corp Reduces Stock Holdings in Novartis AG (NYSE:NVS)Saturna Capital Corp lessened its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 2.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 318,018 shares of the company's stock after selling 8,395 shares during the period. Saturna Capital Corp's hNovember 13, 2024 | marketbeat.comChase Investment Counsel Corp Cuts Stock Position in Novartis AG (NYSE:NVS)Chase Investment Counsel Corp trimmed its position in shares of Novartis AG (NYSE:NVS - Free Report) by 9.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 48,599 shares of the company's stock after selling 5,282 shares during the period. NovartiNovember 13, 2024 | marketbeat.comHemenway Trust Co LLC Trims Position in Novartis AG (NYSE:NVS)Hemenway Trust Co LLC trimmed its position in Novartis AG (NYSE:NVS - Free Report) by 44.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,189 shares of the company's stock after selling 8,791 shares during the period. Hemenway Trust Co LLC's hoNovember 12, 2024 | marketbeat.comNovartis Hold Rating Reflects Cautious Outlook Amid Growth Challenges and Competitive PressuresNovember 12, 2024 | markets.businessinsider.comSchrödinger's stock pops as it enters collaboration pact with Novartis worth up to $2.5 billionNovember 12, 2024 | marketwatch.comSchrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with NovartisNovember 12, 2024 | businesswire.comCrossmark Global Holdings Inc. Increases Stake in Novartis AG (NYSE:NVS)Crossmark Global Holdings Inc. raised its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 28.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 35,617 shares of the company's stock after buying anNovember 12, 2024 | marketbeat.comKennebec Savings Bank Acquires New Shares in Novartis AG (NYSE:NVS)Kennebec Savings Bank bought a new stake in Novartis AG (NYSE:NVS - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,382 shares of the company's stock, valued at approximately $619,000.November 11, 2024 | marketbeat.comSpiderRock Advisors LLC Buys New Stake in Novartis AG (NYSE:NVS)SpiderRock Advisors LLC purchased a new position in Novartis AG (NYSE:NVS - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 11,226 shares of the company's stock, valued at approximately $1,291,00November 11, 2024 | marketbeat.comNovartis AG (NYSE:NVS) Shares Purchased by Assetmark Inc.Assetmark Inc. raised its stake in Novartis AG (NYSE:NVS - Free Report) by 4.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 223,996 shares of the company's stock after acquiring an additional 10,290 shareNovember 10, 2024 | marketbeat.comCWA Asset Management Group LLC Purchases Shares of 25,676 Novartis AG (NYSE:NVS)CWA Asset Management Group LLC purchased a new stake in Novartis AG (NYSE:NVS - Free Report) during the third quarter, according to its most recent filing with the SEC. The fund purchased 25,676 shares of the company's stock, valued at approximately $2,953,000. A number of other institutional invesNovember 10, 2024 | marketbeat.comPrincipal Financial Group Inc. Reduces Stock Position in Novartis AG (NYSE:NVS)Principal Financial Group Inc. reduced its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 0.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,469,568 shares of the company's stock after sellingNovember 8, 2024 | marketbeat.comHarvest Portfolios Group Inc. Sells 19,676 Shares of Novartis AG (NYSE:NVS)Harvest Portfolios Group Inc. reduced its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 3.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 498,263 shares of the company's stock after selling 19,676 shares duringNovember 6, 2024 | marketbeat.comGarland Capital Management Inc. Lowers Stock Position in Novartis AG (NYSE:NVS)Garland Capital Management Inc. trimmed its position in Novartis AG (NYSE:NVS - Free Report) by 15.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,195 shares of the company's stock after selling 7,815 sNovember 5, 2024 | marketbeat.comCambiar Investors LLC Sells 91,047 Shares of Novartis AG (NYSE:NVS)Cambiar Investors LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 42.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 125,609 shares of the company's stock aftNovember 2, 2024 | marketbeat.comNovartis CEO 'very confident' on sales target, doesn't fear patent cliff - newspaperNovember 2, 2024 | reuters.comNovartis (NVS) Gets a Hold from TD CowenNovember 1, 2024 | markets.businessinsider.comPharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in FocusNovember 1, 2024 | msn.comDiversify Wealth Management LLC Takes $704,000 Position in Novartis AG (NYSE:NVS)Diversify Wealth Management LLC purchased a new position in shares of Novartis AG (NYSE:NVS - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 6,168 shares of the company's stock, valued at approximatelyNovember 1, 2024 | marketbeat.comNovartis AG (NYSE:NVS) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | msn.comPositive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst HighlightsOctober 30, 2024 | benzinga.comBMO Capital Markets Increases Novartis (NYSE:NVS) Price Target to $120.00BMO Capital Markets upped their price target on Novartis from $118.00 to $120.00 and gave the company a "market perform" rating in a research note on Wednesday.October 30, 2024 | marketbeat.comNovartis (NYSE:NVS) Issues Earnings Results, Beats Expectations By $0.12 EPSNovartis (NYSE:NVS - Get Free Report) announced its earnings results on Tuesday. The company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Novartis had a net margin of 33.76% and a return on equity of 34.56%. During the same period in the prior year, the firm earned $1.74 earnings per share.October 30, 2024 | marketbeat.comNovartis AG (NVS) Q3 2024 Earnings Call Highlights: Record Cash Flow and Robust Sales GrowthOctober 30, 2024 | finance.yahoo.comNovartis: It's Not Too Late To Buy This Dividend Stock NowOctober 30, 2024 | seekingalpha.com172,825 Shares in Novartis AG (NYSE:NVS) Acquired by International Assets Investment Management LLCInternational Assets Investment Management LLC acquired a new position in Novartis AG (NYSE:NVS - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 172,825 shares of the company's stock, valued atOctober 30, 2024 | marketbeat.comNovartis: Strong Financials, But Market Skepticism Persists Amid Pipeline ConcernsOctober 30, 2024 | seekingalpha.com Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼0.610.45▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼2712▲NVS Articles Average Week Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News SNY News GSK News TAK News BNTX News TEVA News BGNE News VTRS News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
